Quest Diagnostics Launches Obstetrics Test Panel with Hepatitis C Screening
Quest Diagnostics launched an obstetrics lab test panel that enables physicians to screen pregnant people easily & reliably for hepatitis C.
Read MorePosted by Andy Lundin | Aug 18, 2022 | Company News, Infectious Diseases |
Quest Diagnostics launched an obstetrics lab test panel that enables physicians to screen pregnant people easily & reliably for hepatitis C.
Read MorePosted by Andy Lundin | Aug 18, 2022 | Molecular Diagnostics |
Elevated blood levels of a certain chemokine that promotes osteoclast formation were linked with a higher risk of hip fracture in men.
Read MorePosted by Andy Lundin | Aug 17, 2022 | Emerging & Zoonotic Diseases |
Chembio Diagnostics, a POC diagnostics company focused on infectious diseases, is evaluating the potential to develop a monkeypox test.
Read MorePosted by Andy Lundin | Aug 16, 2022 | Company News, Womens Health |
Nanopath will develop & commercialize a biosensing platform that aims to transform how women’s pelvic & gynecologic infections are diagnosed.
Read MorePosted by Andy Lundin | Aug 15, 2022 | Colorectal, Pancreatic |
Personalis and BC Cancer will deploy a personalized liquid biopsy-based assay for a study of patients with colorectal and pancreatic cancers.
Read More